Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer
Titel:
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer
Auteur:
Riudavets, Mariona Auclin, Edouard Mosteiro, Miguel Dempsey, Naomi Majem, Margarita Prelaj, Arsela López-Castro, Rafael Bosch-Barrera, Joaquim Pilotto, Sara Escalera, Elena Tagliamento, Marco Mosquera, Joaquin Zalcman, Gérard Aboubakar Nana, Frank Ponce, Santiago Albarrán-Artahona, Víctor Dal Maso, Alessandro Spotti, Martina Mielgo, Xabier Mussat, Elodie Reyes, Roxana Benítez, Jose-Carlos Lupinacci, Lorena Duchemann, Boris De Giglio, Andrea Blaquier, Juan Bautista Audigier-Valette, Clarisse Scheffler, Matthias Nadal, Ernest Lopes, Gilberto Signorelli, Diego Garcia-Campelo, Rosario Menis, Jessica Bluthgen, Virginia Campayo, Marc Recondo, Gonzalo Besse, Benjamin Mezquita, Laura Planchard, David